281 related articles for article (PubMed ID: 16361260)
1. Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice.
Lee EB; Leng LZ; Zhang B; Kwong L; Trojanowski JQ; Abel T; Lee VM
J Biol Chem; 2006 Feb; 281(7):4292-9. PubMed ID: 16361260
[TBL] [Abstract][Full Text] [Related]
2. Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist.
Fitz NF; Castranio EL; Carter AY; Kodali R; Lefterov I; Koldamova R
J Alzheimers Dis; 2014; 41(2):535-49. PubMed ID: 24643138
[TBL] [Abstract][Full Text] [Related]
3. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
4. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
[TBL] [Abstract][Full Text] [Related]
5. Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.
Mably AJ; Liu W; Mc Donald JM; Dodart JC; Bard F; Lemere CA; O'Nuallain B; Walsh DM
Neurobiol Dis; 2015 Oct; 82():372-384. PubMed ID: 26215784
[TBL] [Abstract][Full Text] [Related]
6. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
[TBL] [Abstract][Full Text] [Related]
7. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
8. Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model.
Morales-Corraliza J; Schmidt SD; Mazzella MJ; Berger JD; Wilson DA; Wesson DW; Jucker M; Levy E; Nixon RA; Mathews PM
Neurobiol Aging; 2013 Jan; 34(1):137-45. PubMed ID: 22608241
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
10. Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease.
Zhao M; Wang SW; Wang YJ; Zhang R; Li YN; Su YJ; Zhou WW; Yu XL; Liu RT
Curr Alzheimer Res; 2014 Jan; 11(1):69-78. PubMed ID: 24156260
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice.
Luo F; Rustay NR; Seifert T; Roesner B; Hradil V; Hillen H; Ebert U; Severin JM; Cox BF; Llano DA; Day M; Fox GB
J Pharmacol Exp Ther; 2010 Dec; 335(3):580-8. PubMed ID: 20823195
[TBL] [Abstract][Full Text] [Related]
12. Brain oligomeric β-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice.
DaRocha-Souto B; Scotton TC; Coma M; Serrano-Pozo A; Hashimoto T; Serenó L; Rodríguez M; Sánchez B; Hyman BT; Gómez-Isla T
J Neuropathol Exp Neurol; 2011 May; 70(5):360-76. PubMed ID: 21487307
[TBL] [Abstract][Full Text] [Related]
13. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.
Caccamo A; Maldonado MA; Bokov AF; Majumder S; Oddo S
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22687-92. PubMed ID: 21149712
[TBL] [Abstract][Full Text] [Related]
14. Reversible memory loss in a mouse transgenic model of Alzheimer's disease.
Kotilinek LA; Bacskai B; Westerman M; Kawarabayashi T; Younkin L; Hyman BT; Younkin S; Ashe KH
J Neurosci; 2002 Aug; 22(15):6331-5. PubMed ID: 12151510
[TBL] [Abstract][Full Text] [Related]
15. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
[TBL] [Abstract][Full Text] [Related]
16. Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.
Wilcock DM; DiCarlo G; Henderson D; Jackson J; Clarke K; Ugen KE; Gordon MN; Morgan D
J Neurosci; 2003 May; 23(9):3745-51. PubMed ID: 12736345
[TBL] [Abstract][Full Text] [Related]
17. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease.
Monsonego A; Maron R; Zota V; Selkoe DJ; Weiner HL
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10273-8. PubMed ID: 11517335
[TBL] [Abstract][Full Text] [Related]
18. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
Wilcock DM; Alamed J; Gottschall PE; Grimm J; Rosenthal A; Pons J; Ronan V; Symmonds K; Gordon MN; Morgan D
J Neurosci; 2006 May; 26(20):5340-6. PubMed ID: 16707786
[TBL] [Abstract][Full Text] [Related]
19. A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes.
Hu M; Zhang J; Yang J; Cao Y; Qi J
J Mol Neurosci; 2018 Sep; 66(1):1-9. PubMed ID: 30062438
[TBL] [Abstract][Full Text] [Related]
20. Antibody against Small Aggregated Peptide Specifically Recognizes Toxic Aβ-42 Oligomers in Alzheimer's Disease.
Bodani RU; Sengupta U; Castillo-Carranza DL; Guerrero-Muñoz MJ; Gerson JE; Rudra J; Kayed R
ACS Chem Neurosci; 2015 Dec; 6(12):1981-9. PubMed ID: 26448453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
